Baijin Life Science Holdings Limited (MNNGF) Stock Price & Analysis
Baijin Life Science Holdings Limited (MNNGF) — price $0.15 (0.00%), as of the Nov 20, 2026 trading session; market cap $140M.
Educational signal · not a buy or sell recommendation · How to read this
Baijin Life Science Holdings Limited · MNNGF
Baijin Life Science Holdings Limited is an investment holding company with diverse operations spanning the wholesale distribution of pearls and jewelry products, strategic investment, and financial services. The company also engages in real estate financial assets investment, maintaining a global presence across Hong Kong, the UK, US, Japan, Europe, and the PRC.
Price as of Nov 20, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $0.15 | |
| Change on the day | 0.00% | |
| Market capitalisation | $140M | |
| Price / earnings (trailing) | 157.92 | |
| Shares traded on the day | 128 |
Price & events
Other perspectives
Council score for Baijin Life Science Holdings (MNNGF): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
3 lenses, 3 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 21, 2026
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 9, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 9, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 21, 2026, except a card that shows its own read date.
What is Baijin Life Science Holdings (MNNGF), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Baijin Life Science Holdings Limited (MNNGF) is the company analyzed here. It employs 84 people. In Q4 FY2026 it reported revenue of HK$34M and net income of -HK$40M. The market values it at $140M.
What do the latest results show for Baijin Life Science Holdings (MNNGF)?
Short answer · as of
The most recent reported quarter, Q4 FY2026, carried revenue of HK$34M.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q4 FY2026 | HK$34M | -HK$40M | -HK$0.06 (diluted) |
| Q2 FY2026 | HK$55M | HK$2M | HK$0.0031 (diluted) |
| Q4 FY2025 | HK$65M | HK$6M | HK$0.01 (diluted) |
| Q2 FY2025 | HK$71M | -HK$6M | -HK$0.01 (diluted) |
What are the financial strengths and risks for Baijin Life Science Holdings (MNNGF)?
Short answer · as of
The distress and quality screens read Altman Z 9.44 · Piotroski F 2. Trailing ratios: ROE -24.5% · ROA -6.7% · current ratio 2.97.
Data-derived red flags
- Negative return on equity (-24.5%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held MNNGF in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported MNNGF in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
Investor Questions: MNNGF Stock
These answers are editorial: 1 of these 8 answers is drawn from the MNNGF research dossier (written Jun 15, 2026 by gemini-2.5-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is MNNGF a good stock to buy?
Stock Expert AI does not rate MNNGF buy, sell or hold. Baijin Life Science Holdings Limited has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the MNNGF stock price today?
The last price recorded for Baijin Life Science Holdings Limited (MNNGF), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
How does Baijin Life Science Holdings Limited manage its diverse business segments?
Baijin Life Science Holdings Limited manages its diverse business segments through its structure as an investment holding company. This allows for strategic allocation of capital and resources across its distinct operations: pearls and jewelry, strategic investments, financial services, and real estate financial assets.
What are the key factors to evaluate for MNNGF?
Evaluate MNNGF on fundamentals, analyst consensus, and risk factors. To weigh it, start with the trailing P/E under Price & valuation on this page. Leveraging Cross-Border Trade and Supply Chain Optimization: Given its global operational footprint, Baijin Life Science Holdings Limited can further optimize its supply chain for pearls and jewelry products. Not financial advice.
How frequently does MNNGF data refresh on this page?
MNNGF's price is the last quote we recorded, from the Nov 20, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven MNNGF's recent stock price performance?
Baijin Life Science Holdings Limited (MNNGF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified business model across jewelry, financial services, and real estate financial assets. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider MNNGF overvalued or undervalued right now?
The trailing P/E of Baijin Life Science Holdings Limited (MNNGF) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research MNNGF before investing?
Before investing in Baijin Life Science Holdings Limited (MNNGF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 12 figures on this page — 11 from Financial Modeling Prep (FMP) and 1 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com